We are pleased to announce that Jennifer Che, Managing Director of Eagle IP, was a featured panelist at the annual Fordham Intellectual Property Law & Policy Conference held recently in New York City.

Widely regarded as one of the most prestigious gatherings in the IP world, the Fordham Conference brings together judges, practitioners, and policymakers from across the globe to discuss the most pressing issues in the field. Jennifer contributed her expertise to the China panel, where she engaged in a deep-dive discussion regarding the rapidly shifting intellectual property landscape in the region.

At Eagle IP, we remain committed to staying at the forefront of international IP policy. Jennifer’s participation in this high-level forum underscores our dedication to providing our clients with the most current and sophisticated counsel for their global IP portfolios.

我們過去活動

Recommended Insights

US vs CN: Foreign Filing License Requirements

2022年11月9日
In China, foreign filing requirements are generally very similar to the US — a foreign filing license is required if a foreign application is to be filed first for an invention made in the country. The Chinese equivalent to the US foreign filing license is called a confidentiality examination for foreign filing. According to Chinese […]

RNAi Patent Success in China: Overcoming “Comprising” Claim Challenges

2025年3月10日
An Update on Sufficiency and Inventiveness of RNAi Patents in China RNAi is a fast-developing technology that has gained traction in the pharmaceutical industry as a promising therapeutic agent. It is important to follow closely RNAi patent proceedings to learn how different examination boards and courts understand and handle these new technologies. The first-ever invalidation […]

No More Hindsight Bias: China’s Supreme People's Court Reins in Patent Inventiveness Assessments

2026年6月25日
For foreign applicants navigating patent litigation or invalidation in China, a common frustration is hindsight bias. Too often, CNIPA or lower courts strip down a patent into isolated technical features, find those features across disparate prior art references, and declare the invention to be "obvious". To counter such hindsight reasoning, the core criterion has always […]

New Policies to Promote Importation of Innovative Drugs

2018年11月8日
At the April 12, 2018 executive meeting of the State Council in China, Premier Mr. Li Keqiang indicated the government’s desire to increase China’s access to innovative drugs. To achieve this, the government would encourage importation of innovative drugs into China by streamlining the regulatory pathway, enhancing IP protection, and lowering the cost of medicine. […]
Top crossarrow-right